{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:07:58Z","timestamp":1761005278917,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Netherlands Organization for Scientific Research","award":["916.13.028"],"award-info":[{"award-number":["916.13.028"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.annepidem.2015.10.007","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T16:30:22Z","timestamp":1446913822000},"page":"85-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unmeasured confounding in pharmacoepidemiology"],"prefix":"10.1016","volume":"26","author":[{"given":"Rolf H.H.","family":"Groenwold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.H.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhivya","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick C.","family":"Souverein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf H.","family":"Klungel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2015.10.007_bib1","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/ije\/dyn173","article-title":"Quantifying the potential role of unmeasured confounders: the example of influenza vaccination","volume":"37","author":"Groenwold","year":"2008","journal-title":"Int J Epidemiol"},{"year":"1987","series-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","key":"10.1016\/j.annepidem.2015.10.007_bib2"},{"key":"10.1016\/j.annepidem.2015.10.007_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/aje\/kwi192","article-title":"Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration","volume":"162","author":"St\u00fcrmer","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annepidem.2015.10.007_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.aje.a113266","article-title":"A\u00a0two stage design for the study of the relationship between a rare exposure and a rare disease","volume":"115","author":"White","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"10.1016\/j.annepidem.2015.10.007_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/pds.3248","article-title":"Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics","volume":"21","author":"Toh","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.annepidem.2015.10.007_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jval.2012.10.012","article-title":"Evaluating the impact of unmeasured confounding with internal validation data: an example cost evaluation in type 2 diabetes","volume":"16","author":"Faries","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.annepidem.2015.10.007_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.atherosclerosis.2011.06.023","article-title":"Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI","volume":"217","author":"Peters","year":"2011","journal-title":"Atherosclerosis"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279715004469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279715004469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:17:33Z","timestamp":1760926653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279715004469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1047279715004469"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2015.10.007","relation":{},"ISSN":["1047-2797"],"issn-type":[{"type":"print","value":"1047-2797"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmeasured confounding in pharmacoepidemiology","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2015.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}